<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb1680">
 <element-citation publication-type="journal" id="rf1635">
  <person-group person-group-type="author">
   <name>
    <surname>Teruya</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Hattori</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Shimamoto</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kobayashi</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Sanjoh</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Nakagawa</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Yamashita</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Akaji</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Structural basis for the development of SARS 3CL protease inhibitors from a peptide mimic to an aza-decaline scaffold</article-title>
  <source>Pept. Sci.</source>
  <volume>106</volume>
  <issue>4</issue>
  <year>2016</year>
  <fpage>391</fpage>
  <lpage>403</lpage>
 </element-citation>
</ref>
